Immune responses to inhalant allergens.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 3650949)

Published in World Allergy Organ J on June 01, 2008

Authors

Wayne R Thomas1, Belinda J Hales

Author Affiliations

1: From the Centre for Child Health Research, University of Western Australia, Telethon Institute for Health Research, Western Australia.

Articles cited by this

(truncated to the top 100)

Foxp3 in control of the regulatory T cell lineage. Nat Immunol (2007) 5.94

Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med (2004) 3.83

Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med (2007) 3.66

Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet (2002) 3.61

Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet (2001) 3.06

Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet (2004) 3.05

New developments in FcepsilonRI regulation, function and inhibition. Nat Rev Immunol (2007) 2.99

Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. Immunity (2006) 2.95

IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol (2003) 2.62

An immunoepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children. Lancet (2005) 2.39

Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax. J Infect Dis (2004) 2.29

Unique maturation program of the IgE response in vivo. Immunity (2007) 2.15

Short-course montelukast for intermittent asthma in children: a randomized controlled trial. Am J Respir Crit Care Med (2006) 2.10

The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest (2001) 2.05

Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology (2006) 2.03

Cutting edge: direct action of thymic stromal lymphopoietin on activated human CD4+ T cells. J Immunol (2007) 2.03

The crystal structure of IgE Fc reveals an asymmetrically bent conformation. Nat Immunol (2002) 1.89

Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma. Am J Respir Crit Care Med (2004) 1.88

Quantitative measurement of IgE antibodies to purified allergens using streptavidin linked to a high-capacity solid phase. J Allergy Clin Immunol (2005) 1.87

Chemokine-receptor expression on T cells in lung compartments of challenged asthmatic patients. Clin Exp Allergy (2005) 1.76

Characteristics and immunobiology of grass pollen allergens. Int Arch Allergy Immunol (2003) 1.64

Purification and characterization of the major allergen from Dermatophagoides pteronyssinus-antigen P1. J Immunol (1980) 1.63

IgE antibody quantification and the probability of wheeze in preschool children. J Allergy Clin Immunol (2005) 1.58

Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma. Am J Respir Crit Care Med (2004) 1.53

The biology and therapeutic potential of interleukin 27. J Mol Med (Berl) (2007) 1.47

IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-gamma expression. Immunology (1997) 1.37

Specific IgE and IgG antibody-binding patterns to recombinant cockroach allergens. J Allergy Clin Immunol (2005) 1.33

Local production of IgG, IgA and IgE antibodies in grass pollen hay fever. J Immunol (1979) 1.32

IgE and IgG anti-house dust mite specificities in allergic disease. J Allergy Clin Immunol (2006) 1.29

A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen. J Immunol (2004) 1.28

Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions. J Allergy Clin Immunol (2003) 1.25

Divergent generation of heterogeneous memory CD4 T cells. J Immunol (2006) 1.17

IgA and IgG anti-ragweed antibodies in nasal secretions. Quantitative measurements of antibodies and correlation with inhibition of histamine release. J Clin Invest (1976) 1.17

Use of a chimeric ELISA to investigate immunoglobulin E antibody responses to Der p 1 and Der p 2 in mite-allergic patients with asthma, wheezing and/or rhinitis. Clin Exp Allergy (2002) 1.16

Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production. J Allergy Clin Immunol (2003) 1.16

Quantitative measurement of airborne allergens from dust mites, dogs, and cats using an ion-charging device. Clin Exp Allergy (2003) 1.16

Frequency of immunoglobulin E class switching is autonomously determined and independent of prior switching to other classes. J Exp Med (1994) 1.15

Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization. Int Arch Allergy Immunol (2002) 1.15

Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. J Immunol (1995) 1.14

Measurement of IgG, IgA and IgE antibodies to Dermatophagoides pteronyssinus by antigen-binding assay, using a partially purified fraction of mite extract (F4P1). Clin Exp Immunol (1978) 1.13

Allergen-specific production of interferon-gamma by peripheral blood mononuclear cells and CD8 T cells in allergic disease and following immunotherapy. Clin Exp Allergy (2000) 1.13

Inefficient processing of mRNA for the membrane form of IgE is a genetic mechanism to limit recruitment of IgE-secreting cells. Eur J Immunol (2006) 1.11

Increased interleukin-10 messenger RNA expression in atopic allergy and asthma. Am J Respir Cell Mol Biol (1996) 1.11

Regulation of T-helper cell responses to inhalant allergen during early childhood. Clin Exp Allergy (1999) 1.09

Increased Th1 and Th2 allergen-induced cytokine responses in children with atopic disease. Clin Exp Allergy (2002) 1.08

Persistent central memory phenotype of circulating Fel d 1 peptide/DRB1*0101 tetramer-binding CD4+ T cells. J Allergy Clin Immunol (2006) 1.08

Pulmonary chemokines and their receptors differentiate children with asthma and chronic cough. J Allergy Clin Immunol (2005) 1.07

Allergen-specific CD8(+) T cells and atopic disease. J Clin Invest (2002) 1.07

Mouse allergen-specific antibody responses in inner-city children with asthma. J Allergy Clin Immunol (2007) 1.05

Immunoglobulin E antibodies to pollen allergens account for high percentages of total immunoglobulin E protein. Science (1975) 1.04

Cat and dust mite allergen levels, specific IgG and IgG4, and respiratory symptoms in adults. J Allergy Clin Immunol (2007) 1.03

Production and proteomic characterization of pharmaceutical-grade Dermatophagoides pteronyssinus and Dermatophagoides farinae extracts for allergy vaccines. Int Arch Allergy Immunol (2006) 1.03

Detection and characterization of plasma cells in peripheral blood: correlation of IgE+ plasma cell frequency with IgE serum titre. Clin Exp Immunol (2002) 1.01

Fel d 4, a cat lipocalin allergen. Clin Exp Allergy (2004) 1.01

Precursor frequency of antigen-specific T cells: effects of sensitization in vivo and in vitro. Cell Immunol (1983) 1.00

CCR4 in human allergen-induced late responses in the skin and lung. Eur J Immunol (2002) 0.99

Purified natural and recombinant Fel d 1 and cat albumin in in vitro diagnostics for cat allergy. J Allergy Clin Immunol (1999) 0.98

Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA. J Allergy Clin Immunol (2004) 0.98

Allergen-induced Th1 and Th2 cytokine secretion in relation to specific allergen sensitization and atopic symptoms in children. Clin Exp Allergy (2001) 0.96

Genetic variation of Der p 2 allergens: effects on T cell responses and immunoglobulin E binding. Clin Exp Allergy (2002) 0.93

Frequency of allergen-specific T lymphocytes in blood and bronchial response to allergen in asthma. J Allergy Clin Immunol (1993) 0.92

Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation. Bone Marrow Transplant (1998) 0.91

Association between CD4(+)CD25(high) T cells and atopy in children. J Allergy Clin Immunol (2007) 0.91

Development of immunologic memory against tetanus toxoid and pertactin antigens from the diphtheria-tetanus-pertussis vaccine in atopic versus nonatopic children. J Allergy Clin Immunol (2000) 0.88

The human IgE-encoding transcriptome to assess antibody repertoires and repertoire evolution. J Mol Biol (2006) 0.88

FOXP3 mRNA expression at 6 months of age is higher in infants who develop atopic dermatitis, but is not affected by giving probiotics from birth. Pediatr Allergy Immunol (2007) 0.88

T and B cell responses to HDM allergens and antigens. Immunol Res (2007) 0.88

Cytokine responses to Der p 1 and Der p 7: house dust mite allergens with different IgE-binding activities. Clin Exp Allergy (2000) 0.87

Human subjects without peanut allergy demonstrate T cell-dependent, TH2-biased, peanut-specific cytokine and chemokine responses independent of TH1 expression. J Allergy Clin Immunol (2006) 0.87

Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1 *01. J Allergy Clin Immunol (2005) 0.86

The pattern of human late-phase skin reactions to extracts of aeroallergens. J Allergy Clin Immunol (1988) 0.86

Immune regulation by CD4+CD25+ T cells and interleukin-10 in birch pollen-allergic patients and non-allergic controls. Clin Exp Allergy (2007) 0.86

Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients. Int Arch Allergy Immunol (2004) 0.85

T cell responses to the purified major allergens from the house dust mite Dermatophagoides pteronyssinus. J Allergy Clin Immunol (1992) 0.85

IL-10 production in circulating T cells differs between allergen-induced isolated early and dual asthmatic responders. J Allergy Clin Immunol (2002) 0.84

Emerging pollen allergens. Biomed Pharmacother (2006) 0.83

Antigen mediated and polyclonal stimulation of human cytokine production elicit qualitatively different patterns of cytokine gene expression. Int Immunol (1995) 0.83

Early-onset atopy is associated with enhanced lymphocyte cytokine responses in 11-year-old children. Clin Exp Allergy (2007) 0.82

Comparison of purified Dermatophagoides pteronyssinus allergens and extract by two-dimensional immunoblotting and quantitative immunoglobulin E inhibitions. Clin Exp Allergy (2005) 0.82

Reciprocal patterns of allergen-induced GATA-3 expression in peripheral blood mononuclear cells from atopics vs. non-atopics. Clin Exp Allergy (2002) 0.81

Allergen-reactive antibodies are found in nasal fluids from patients with birch pollen-induced intermittent allergic rhinitis, but not in healthy controls. Allergy (2003) 0.81

Immunoglobulin E antibodies of atopic individuals exhibit a broad usage of VH-gene families. Immunology (2000) 0.81

Seasonal dynamics of chemokine receptors and CD62L in subjects with asymptomatic skin sensitization to birch and grass pollen. Allergy (2006) 0.81

Distribution of IgE and IgG antibody levels against house dust mites in schoolchildren, and their relation with asthma. J Asthma (1997) 0.81

Quantifying serum antibody in bird fanciers' hypersensitivity pneumonitis. BMC Pulm Med (2006) 0.81

House dust mite-specific T cells in healthy non-atopic children. Clin Exp Allergy (2005) 0.80

Allergen-specific T cells from birch-pollen-allergic patients and healthy controls differ in T helper 2 cytokine and in interleukin-10 production. Clin Exp Allergy (2004) 0.80

Immune memory in CD4+ CD45RA+ T cells. Immunology (1997) 0.80

In vitro kinetics of allergen- and microbe-induced IL-4 and IFN-gamma mRNA expression in PBMC of pollen-allergic patients. Allergy (2003) 0.79

Mouse allergen-specific immunoglobulin G4 and risk of mouse skin test sensitivity. Clin Exp Allergy (2006) 0.78

Immunological characteristics of subjects with asymptomatic skin sensitization to birch and grass pollen. Clin Exp Allergy (2006) 0.78

Seasonal variation of in vitro lymphocyte proliferative response to ragweed antigen E. J Allergy Clin Immunol (1985) 0.78

T cell cytokine responses to outer membrane proteins of Haemophilus influenzae and the house dust mite allergens Der p 1 in allergic and non-allergic subjects. Clin Exp Allergy (2002) 0.77

In vitro and in vivo allergenicity of recombinant Bet v 1 compared to the reactivity of natural birch pollen extract. Clin Exp Allergy (2003) 0.77

Increment of recombinant hepatitis B surface antigen-specific T-cell precursors after revaccination of slow responder children. Vaccine (2001) 0.76

Differential recognition of recombinant Phl p 5 isoallergens by Phl p 5-specific T cells. Int Arch Allergy Immunol (1999) 0.76

Quantitation of IgE antibody specific for ragweed and grass allergens: binding of radiolabeled allergens by solid-phase bound IgE. J Allergy Clin Immunol (1978) 0.76

Cd4(+) T cell response to Leishmania spp. in non-infected individuals. Hum Immunol (2000) 0.75

Characterization of the human T cell response to rye grass pollen allergens Lol p 1 and Lol p 5. Allergy (2002) 0.75

Allergen-driven limiting dilution analysis of human IL-4 and IFN-gamma production in allergic rhinitis and clinically tolerant individuals. Int Immunol (1996) 0.75

Articles by these authors

Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. J Immunol (2009) 1.97

House dust mite allergens in asthma and allergy. Trends Mol Med (2010) 1.68

Characterization and immunobiology of house dust mite allergens. Int Arch Allergy Immunol (2002) 1.61

The allergenic specificities of the house dust mite. Chang Gung Med J (2004) 1.28

Structural biology of allergens. Curr Allergy Asthma Rep (2005) 1.22

House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells. Am J Respir Crit Care Med (2009) 1.10

Defective respiratory tract immune surveillance in asthma: a primary causal factor in disease onset and progression. Chest (2014) 0.95

FOXP3 mRNA expression at 6 months of age is higher in infants who develop atopic dermatitis, but is not affected by giving probiotics from birth. Pediatr Allergy Immunol (2007) 0.88

T and B cell responses to HDM allergens and antigens. Immunol Res (2007) 0.88

Effect of early carriage of Streptococcus pneumoniae on the development of pneumococcal protein-specific cellular immune responses in infancy. Pediatr Infect Dis J (2012) 0.85

Reduced rhinovirus-specific antibodies are associated with acute exacerbations of chronic obstructive pulmonary disease requiring hospitalisation. BMC Pulm Med (2012) 0.85

Increased allergic immune response to Sarcoptes scabiei antigens in crusted versus ordinary scabies. Clin Vaccine Immunol (2010) 0.83

Species-specific and cross-reactive IgG1 antibody binding to viral capsid protein 1 (VP1) antigens of human rhinovirus species A, B and C. PLoS One (2013) 0.79

Using time-resolved fluorescence to measure serum venom-specific IgE and IgG. PLoS One (2011) 0.78

Recombinant allergens for analysing T-cell responses. Methods (2004) 0.76

Genetically engineered vaccines. Curr Allergy Asthma Rep (2005) 0.76